CTA
CELG

Carillon Tower Advisers’s Celgene Corp CELG Stock Holding History

Carillon Tower Advisers’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-27,300
Closed -$2.71M – 498
2019
Q3 		$2.71M Sell
27,300
-800
-3% -$76K 0.02% 443
2019
Q2 		$2.6M Hold
28,100
– – 0.02% 443
2019
Q1 		$2.65M Sell
28,100
-13,900
-33% -$1.22M 0.02% 436
2018
Q4 		$2.69M Buy
+42,000
New +$3.1M 0.02% 412
2018
Q3 		– Sell
-27,600
Closed -$2.19M – 494
2018
Q2 		$2.19M Buy
+27,600
New +$2.29M 0.02% 436

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Carillon Tower Advisers's CELG Position: Q4 2019 in Review

Carillon Tower Advisers sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 27,300 shares — an estimated $2.71M sold.

Carillon Tower Advisers first reported a position in CELG in Q2 2018 and held it in 5 quarters. The position peaked at $2.71M in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Carillon Tower Advisers reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Carillon Tower Advisers sold 27,300 Celgene Corp shares in Q4 2019, an estimated $2.71M.
  • Carillon Tower Advisers first reported a position in Celgene Corp in Q2 2018 and held it in 5 quarters.
  • Carillon Tower Advisers's Celgene Corp position peaked at $2.71M in Q3 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Carillon Tower Advisers's 13F filing for Q4 2019, filed 11 Feb 2020.